U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07194824) titled 'A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients' on Sept. 19.

Brief Summary: Design, implementation and analysis of an allergy assessment and management model beta-lactams in hospitalized patients

Study Start Date: April 04, 2024

Study Type: INTERVENTIONAL

Condition: Evaluation and Management Model for Beta-lactam Allergy in Hospitalized Patients

Intervention: OTHER: Pragmatic allergy management according to risk stratification

Intervention based on allergy risk stratification. Tipus A) Patients in this group can undergo direct delabeling without the need for exposure, with this being documented in the...